INmune Bio, Inc. Announces Interim Phase Ib Data Demonstrating That XPro1595 Decreases Neuroinflammation in Patients with Alzheimer's Disease
Stock Information for INmune Bio Inc.
Loading
Please wait while we load your information from QuoteMedia.